Worth Watching Stocks: Planet Payment, Inc. (NASDAQ:PLPM), Medgenics, Inc. (NYSEMKT:MDGN), CytRx Corporation (NASDAQ:CYTR), ServiceNow, Inc. (NYSE:NOW), Johnson & Johnson (NYSE:JNJ)

Biotie Therapies Corp. (NASDAQ:BITI) belongs to Healthcare sector. Its weekly performance is 10.60%. On last trading day company shares ended up $20.34. Biotie Therapies Corp. (NASDAQ:BITI) distance from 50-day simple moving average (SMA50) is 0.81%. Roth Capital assumed coverage on shares of Biotie Therapies Corp. (NASDAQ:BITI) in a research note issued on Tuesday. The firm set a “buy” rating and a $26.00 price target on the stock. Roth Capital’s price objective points to a potential upside of 33.74% from the stock’s previous close.

Medgenics, Inc. (NYSEMKT:MDGN) shares moved up 6.07% in last trading session and ended the day at $6.47. MDGN return on assets is -91.50%. Medgenics, Inc. (NYSEMKT:MDGN) quarterly performance is -25.55%. On 29 June, Medgenics, Inc. (NYSEMKT:MDGN) announced that it has been added to the Russell 3000® and Russell Global Indexes as part of Russell Investments’ annual reconstitution

On 10 July, CytRx Corporation (NASDAQ:CYTR) shares moved up 5.72% and was closed at $3.88. CYTR EPS growth in last 5 year was -10.10%. CytRx Corporation (NASDAQ:CYTR) year to date (YTD) performance is 41.61%. On 3 June, CytRx Corporation (NASDAQ:CYTR) unveiled its proprietary LADR (Linker Activated Drug Release) technology platform, a discovery engine designed to leverage the Company’s expertise in albumin biology and linker technology for the development of a new class of anti-cancer therapies.

ServiceNow, Inc. (NYSE:NOW) belongs to Technology sector. Its net profit margin is -25.70% and weekly performance is 2.97%. On last trading day company shares ended up $76.74. ServiceNow, Inc. (NYSE:NOW) distance from 50-day simple moving average (SMA50) is 0.34%. ServiceNow, Inc. (NYSE:NOW) announced it will release financial results for the second quarter 2015 ended June 30, 2015 following the close of market on Wednesday, July 29, 2015. ServiceNow will host a conference call and live webcast to discuss the financial results.

Johnson & Johnson (NYSE:JNJ) shares advanced 1.15% in last trading session and ended the day at $99.53. JNJ Gross Margin is 69.30% and its return on assets is 15.70%. Johnson & Johnson (NYSE:JNJ) quarterly performance is -1.77%. On 2 July, Johnson & Johnson (NYSE:JNJ) announced that it has collaborated with an international team of experts to conduct a study and test the effectiveness of an HIV vaccine regimen on non-human primates. J&J said results of the preclinical study are now published in the online journal Science.

Leave a Reply

Your email address will not be published. Required fields are marked *